In a native, non-transplant Pax5 mutant mouse model where B-ALL arises naturally, inhibition of IL-6 with a neutralizing antibody was shown to significantly reduce disease progression [136]. The gene discussed is IL6; the disease is precursor B-cell acute lymphoblastic leukemia.